FORTREA HOLDINGS INC (FTRE)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for FTRE
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| FTRE | Director | 62 | ["General Management and Business Operations","Technology","Finance/Accounting","Mergers and Acquisitions","International Business","Healthcare/Drug Development","Science and Medicine","Spin Experience","Accomplished biopharmaceutical leader","Expertise in quality, compliance, operations, and organizational transformation","Senior leadership roles at Biogen, Inc.","Served as North Carolina’s Secretary of Commerce","Served as Secretary of Administration","Board member at BioCryst Pharmaceuticals, Inc.","Previous board member of Novan, Inc. and Radius Health, Inc.","Bachelor of Science in Biochemistry","Master’s in Health Administration","Continued executive development through Stanford University’s Directors’ Consortium"] | ["science committee","chairperson of the compensation committee"] | 2026 |
Biography sourced from the proxy statement filing.
Ms. Sanders has served as a director since May 2024. Ms. Sanders is an accomplished biopharmaceutical and public-sector leader with deep expertise in quality, compliance, operations, and large-scale organizational transformation. She has held senior leadership roles at Biogen, Inc., including Vice President of Multiple Sclerosis Franchise Product Operations where she led global operational strategies, life cycle management, and regulatory execution for therapies and Vice President of Manufacturing & General Manager of the RTP, NC site, overseeing 1,200 employees, biologics and small-molecule operations, major capital expansions, and global regulatory approvals. Her executive experience extends to state government, serving as North Carolina s Secretary of Commerce from February 2021 to January 2025 and Secretary of Administration from January 2017 to February 2021, where she led statewide economic development, workforce strategy, and government operations. Since February 2022, she has served on the board of BioCryst Pharmaceuticals, Inc., a global public biotechnology company, where she is a member of the science committee and chairperson of the compensation committee. Ms. Sanders previously served as a member of the boards of directors of Novan, Inc. from 2017 to April 2024 and Radius Health, Inc. from 2021 to August 2022. Ms. Sanders earned a Bachelor of Science in Biochemistry from North Carolina State University and a Master s in Health Administration from Pfeiffer University. She has also pursued continued executive development through Stanford University s Directors Consortium.